Biotechnology Denali Therapeutics Announces DNL343 Interim Phase 1b Data in ALS and Entry into the HEALEY ALS Platform Trial December 5, 2022
Biotechnology BIO-TECHNE RELEASES MITOBRILLIANT(TM) FLUORESCENT DYES, PROVIDING A NEXT-GENERATION TOOL FOR IMAGING MITOCHONDRIA IN LIVE AND FIXED CELLS December 5, 2022
Biotechnology Moore Kuehn, PLLC Encourages Investors of Allogene Therapeutics, Inc. to Contact Law Firm December 4, 2022
Biotechnology Ultragenyx (RARE) Down 0.9% Since Last Earnings Report: Can It Rebound? December 2, 2022
Health Allogene Therapeutics (ALLO) Down 1.6% Since Last Earnings Report: Can It Rebound? December 2, 2022
Search
Health
